Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

GeneNews Ltd. (TSE: GEN)

 
GEN Technical Analysis
5
As on 31st Oct 2017 GEN Share Price closed @ 0.08 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.25 & Strong Sell for SHORT-TERM with Stoploss of 0.10 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

GEN Share Price

Open 0.08 Change Price %
High 0.08 1 Day 0.00 0.00
Low 0.08 1 Week 0.00 0.00
Close 0.08 1 Month -0.01 -11.11
Volume 138700 1 Year -0.39 -82.98
52 Week High 0.53 | 52 Week Low 0.08
 
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
LSG 2.08 8.33%
TBE 0.03 0.00%
ECA 15.09 4.43%
SC 60.83 -0.44%
PRE 0.64 0.00%
ELD 1.62 -6.90%
MFC 25.94 -0.04%
CPG 10.61 4.53%
BBD-B 2.73 -1.09%
 
TSE Canada Top Gainers Stocks
TVI 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
GGA 0.06 20.00%
ANX 0.07 16.67%
ANX 0.07 16.67%
COM 2.27 14.07%
 
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
NXJ 2.35 -10.31%
NXJ 2.35 -10.31%
RN 0.09 -10.00%
RN 0.09 -10.00%
CTU-A 0.19 -9.52%
TNP 0.90 -9.09%
TNP 0.90 -9.09%
TNX 0.34 -8.11%
QEC 0.74 -7.50%
 
 
GEN
Daily Charts		 GEN
Intraday Charts		 Whats New @
Bazaartrend		 GEN
Free Analysis
 
GEN Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE0.08
RESISTANCE0.08
RESISTANCE0.08
RESISTANCE0.08
SUPPORT0.00
SUPPORT0.00
 
GEN Target for Month October
Share
4th UP TARGET0.12
3rd UP TARGET0.11
2nd UP TARGET0.1
1st UP TARGET0.09
1st DOWN TARGET0.07
2nd DOWN TARGET0.06
3rd DOWN TARGET0.05
4th DOWN TARGET0.04
 
GEN Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
GEN Target for Year 2020
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
GEN Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website >
 
GEN Address
GEN
 445 Apple Creek Boulevard
Suite 220
Markham, ON L3R 9X7
Canada
Phone: 905-739-2030
Fax: 905-739-2031
 
GEN Latest News
 
Your Comments and Response on GeneNews Ltd.
 
GEN Business Profile
GeneNews Limited, a molecular diagnostics company, focuses on the development and application of functional genomics to enable early diagnosis and personalized health management based on disease specific biomarkers. Its principal platform technology, the Sentinel Principle, detects and stages various diseases or medical conditions from a blood sample. The company is applying the Sentinel Principle in the areas of cancer, arthritis, cardiovascular diseases, and neurological disorders. Its lead product includes ColonSentry, a blood-based molecular test to aid physicians in determining an individualÂ’s risk of having colorectal cancer. The company was formerly known as ChondroGene Limited and changed its name to GeneNews Limited in October 2006. GeneNews Limited was founded in 1998 and is headquartered in Markham, Canada.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service